Home > Rheumatology > ACR 2020 > COVID-19 – What Rheumatologists Need to Know > COVID-19 in patients with rheumatic disease: most report mild disease

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By
Dr Akhil Sood, University of Texas Medical Branch, USA
Conference
ACR 2020
A new study presented during the ACR Convergence 2020 demonstrated that patients with rheumatic disease have a low incidence of COVID-19 with most patients having a mild disease course. “When the pandemic started, there was concern on whether to continue or hold immune therapies among patients with rheumatic diseases because they are at increased risk for infection,” says the study’s co-author, Dr Akhil Sood (University of Texas Medical Branch, USA) [1]. To explore the risk for SARS-CoV-2 infection and outcomes in patients with rheumatic disease, the researchers performed a systematic literature search in PubMed/Medline and Scopus to identify relevant studies from January to June 2020 that reported the outcomes of COVID-19 among these patients. The final review included 6,095 patients with rheumatic diseases from 8 observational cohort studies, with 28% having rheumatoid arthritis (RA) and 7% having psoriatic arthritis (PsA). Of the 6,095 patients,...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on